The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Headline
In the latest "Safety Speaks" conversation, Christi Barney, R.N., vice president of quality and patient safety at Emerson Health, discusses the health system’s…
Headline
In a new blog, Chris DeRienzo, M.D., AHA’s senior vice president and chief physician executive, highlights three ways this year's AHA Leadership Summit…
Blog
From plenaries to interactive sessions to podcasts, the AHA’s Patient Safety Initiative had a huge presence at last month’s AHA Leadership Summit. Over three…
Chairperson's File
Today’s health care workforce uses an amazing array of creative approaches, strategies and technology tools to ensure every patient receives quality care.At…
Headline
In a new "Safety Speaks" conversation, Jamie Orlikoff, president of Orlikoff & Associates, Inc. and AHA national adviser on governance and leadership,…
Headline
The Centers for Medicare & Medicaid Services July 31 updated the Overall Hospital Quality Star Ratings at its Care Compare website and Provider Data…